Table II.
Effect of pyruvate kinase isoenzyme M2 on cisplatin sensitivity in different cancers.
Cancer type | Effect | Treatment | (Refs.) |
---|---|---|---|
Bladder cancer | Overcomes resistance | Shikonin | (76,79) |
Hepatocellular carcinoma | Chemosensitivity | MicroRNA-199a | (80) |
Osteosarcoma | Chemosensitivity | Metformin | (47) |
Cervical cancer | Chemosensitivity | PKM2 | (18) |
PKM2, pyruvate kinase isoenzyme M2.